Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study

BACKGROUND: The use of COVID-19 vaccines has been prioritised to protect the most vulnerable—notably, older people. Because of fluctuations in vaccine availability, strategies such as delayed second dose and heterologous prime-boost have been used. However, the effectiveness of these strategies in f...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinh, Donald C, Gouin, Jean-Philippe, Cruz-Santiago, Diana, Canac-Marquis, Michelle, Bernier, Stéphane, Bobeuf, Florian, Sengupta, Avik, Brassard, Jean-Philippe, Guerra, Alyssa, Dziarmaga, Robert, Perez, Anna, Sun, Yichun, Li, Yongbiao, Roussel, Lucie, Langelier, Mélanie J, Ke, Danbing, Arnold, Corey, Whelan, Marilyn, Pelchat, Martin, Langlois, Marc-André, Zhang, Xun, Mazer, Bruce D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863504/
https://www.ncbi.nlm.nih.gov/pubmed/35224524
http://dx.doi.org/10.1016/S2666-7568(22)00012-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863504/
https://www.ncbi.nlm.nih.gov/pubmed/35224524
http://dx.doi.org/10.1016/S2666-7568(22)00012-5

Ejemplares similares